Tonini G - Search Results

1

Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment.

Pantano F, Guida FM, Vivaldi C, Vincenzi B, Grande E, Garrote MR, Caraglia M, Silvestris N, Vasile E, Masi G, Falcone A, Tonini G, Santini D. Pantano F, et al. Among authors: tonini g. Cancer Biol Ther. 2013 Jun;14(6):467-8. doi: 10.4161/cbt.24346. Cancer Biol Ther. 2013. PMID: 23760487 Free PMC article.

2

[The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient].

Santini D, Vincenzi B, Finolezzi E, Di Cosimo S, Gravante G, Spoto S, Tonini G. Santini D, et al. Among authors: tonini g. Minerva Med. 1999 Jul-Aug;90(7-8):205-9. Minerva Med. 1999. PMID: 10719419 Review. Italian. No abstract available.

3

Skin lesions in melanoma and Kaposi's sarcoma. Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression.

Santini D, Tonini G, Vincenzi B, Murace R, Ferranti G, Baldi A. Santini D, et al. Among authors: tonini g. J Clin Oncol. 2002 Mar 1;20(5):1411-2. doi: 10.1200/JCO.2002.20.5.1411. J Clin Oncol. 2002. PMID: 11870187 No abstract available.

4

Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Battistoni F, Gavasci M, Salerno A, Denaro V, Tonini G. Santini D, et al. Among authors: tonini g. Clin Cancer Res. 2002 May;8(5):1080-4. Clin Cancer Res. 2002. PMID: 12006522 Clinical Trial.

5

Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.

Tonini G, Santini D, Vincenzi B, Borzomati D, Dicuonzo G, La Cesa A, Onori N, Coppola R. Tonini G, et al. J Biol Regul Homeost Agents. 2002 Apr-Jun;16(2):105-9. J Biol Regul Homeost Agents. 2002. PMID: 12144121 Clinical Trial.

6

Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor.

Vespasiani Gentilucci U, Santini D, Picardi A, Vincenzi B, Riva E, Bianchi A, Tonini G. Vespasiani Gentilucci U, et al. Among authors: tonini g. J Interferon Cytokine Res. 2002 Jun;22(6):683-8. doi: 10.1089/10799900260100178. J Interferon Cytokine Res. 2002. PMID: 12162879

7

Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count.

Tonini G, Santini D, Vincenzi B, Dicuonzo G, Salerno A, Finolezzi E, Avvisati G. Tonini G, et al. Acta Oncol. 2002;41(3):315-6. doi: 10.1080/02841860260088881. Acta Oncol. 2002. PMID: 12195753 No abstract available.

8

Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.

Bianco V, Rozzi A, Tonini G, Santini D, Magnolfi E, Vincenzi B, D'Angelillo R, Marchei P. Bianco V, et al. Among authors: tonini g. Anticancer Res. 2002 Sep-Oct;22(5):3053-6. Anticancer Res. 2002. PMID: 12530041 Clinical Trial.

9

Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.

Romiti A, Tonini G, Santini D, Di Seri M, Masciangelo R, Mezi S, Verì A, Santuari L, Vincenzi B, Brescia A, Marchei P, Frati L, Tomao S. Romiti A, et al. Among authors: tonini g. Anticancer Res. 2002 Sep-Oct;22(5):3071-6. Anticancer Res. 2002. PMID: 12530045

10

Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient.

Santini D, Picardi A, Vincenzi B, Binetti P, Massacesi C, La Cesa A, Tonini G. Santini D, et al. Among authors: tonini g. Cancer Invest. 2003;21(1):162-3. doi: 10.1081/cnv-120016411. Cancer Invest. 2003. PMID: 12643018 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,007 results

Search Page

Filters